Table 2.

Current COVID-19 Vaccines Available in the United States

Vaccine	Type	Age Authorized for Use in the United States	Comments
BNT162b2 (tozinameran; Comirnaty) [Pfizer Inc and BioNTech]	mRNA	12 years of age and above; approved for use in individuals 16 years of age and above	EUA in the United States, EU, and other countries
			Approved in the United States, Canada, and other countries
			2 shots, 21 days apart
mRNA-1273 (Spikevax) [ModernaTx Inc]	mRNA	18 years of age and above	EUA in the United States, EU, and other countries, Approved in Canada and Switzerland
			2 shots, 28 days apart
JNJ-78326735/Ad26.COV2.S [Janssen/Johnson & Johnson]	Replication-defective adenoviral vector	18 years of age and above	EUA in the United States, EU, Canada, and other countries
			1 shot

Abbreviation: EUA, emergency use authorization.